Format

Send to

Choose Destination
Clin Genitourin Cancer. 2017 Dec;15(6):e1127-e1130. doi: 10.1016/j.clgc.2017.05.028. Epub 2017 Jun 3.

Rapid Response to Nivolumab in a Patient With Sarcomatoid Transformation of Chromophobe Renal Cell Carcinoma.

Author information

1
Department of Oncology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel. Electronic address: kerenro@clalit.org.il.
2
Department of Pathology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
3
Department of Radiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
4
Department of Oncology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.

KEYWORDS:

Chromophobe renal cell carcinoma; Nivolumab; Non–clear-cell renal cell carcinoma; Programmed death 1 inhibitor; Sarcomatoid transformation

PMID:
28673798
DOI:
10.1016/j.clgc.2017.05.028
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center